Toronto Innovation Acceleration Partners (TIAP)
Toronto, ON
Investment Thesis
TIAP specializes in venture building of early-stage health science technologies (therapeutics, medical devices, and digital health) emerging from University of Toronto and Toronto teaching hospitals. The fund transforms research spinouts into successful Canadian ventures through equity investment (CAD $50K–$3.2M), expert advisory, and access to a global network of industry advisors and investors.
Focus Areas
Investment Stage
Pre-SeedSeed
Investment Signals
Check SizeC$50K to C$3.2M
GeographyCanada-focused
ProvincesON
RoleLead
Revenue Stagepre-revenue ok
Impact MandateYes
Business ModelsB2B, deep-tech, hardware, IP-licensing
Sample Portfolio Companies
AmacaThera
CoHealth
NerveX Neurotechnologies Inc.
Dalriada Drug Discovery Inc.
eQOL
Structura Biotechnology
Cohesys
Micellae Delivery Systems
Phycus
Tabiat Research
EBT Medical
ODAIA
AUM & Sources
N/A
Assets under management (estimated)
Sources
No public sources found.
Raising from Canadian VCs?Get AI-matched to your top investors in seconds.
Find My Investors →Similar Funds
See incorrect information?
Help us keep this directory accurate and up to date.